Regeneron Pharmaceuticals
REGN
#287
Rank
NZ$138.93 B
Marketcap
NZ$1,311
Share price
-0.63%
Change (1 day)
6.77%
Change (1 year)

Regeneron Pharmaceuticals (REGN) Fails to deliver data

Key failure to deliver metrics for Regeneron Pharmaceuticals:

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Regeneron Pharmaceuticals (REGN) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Regeneron Pharmaceuticals (REGN) - since 2013

Volume in USD (price x number of shares), data since 2013

Regeneron Pharmaceuticals (REGN) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2025NZ$69.31 M-21.01%
2024NZ$87.75 M-26.52%
2023NZ$0.11 B-5.6%
2022NZ$0.12 B-53.05%
2021NZ$0.26 B5.23%
2020NZ$0.25 B414.86%
2019NZ$49.73 M-31.98%
2018NZ$73.11 M69.52%
2017NZ$43.12 M-78.72%
2016NZ$0.20 B3.03%
2015NZ$0.19 B-15.29%
2014NZ$0.23 B419.89%
2013NZ$44.67 M

FTD volume in the last 3 months for similar companies or competitors

Company FTD volume (3 months) FTD volume (1 year) Country
Amgen
AMGN
NZ$23.42 MNZ$0.20 B๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
NZ$9.04 MNZ$42.05 M๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
NZ$3.38 MNZ$79.73 M๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
NZ$55.75 MNZ$0.10 B๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$49.62 MNZ$0.10 B๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Sanofi
SNY
NZ$11.8 MNZ$69.68 M๐Ÿ‡ซ๐Ÿ‡ท France